|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen WQ, Zheng RS, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer Statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dey H and Liu ZR: Phosphorylation of P68
RNA Helicase by P38 MAP kinase contributes to colon cancer cells
apoptosis induced by oxaliplatin. BMC Cell Biol. 13:272012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martinez-Balibrea E, Martínez-Cardús A,
Ginés A, Ruiz de Porras V, Moutinho C, Layos L, Manzano JL, Bugés
C, Bystrup S, Esteller M and Abad A: Tumor-related molecular
mechanisms of oxaliplatin resistance. Mol Cancer Ther.
14:1767–1776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raman R, Raguram S, Venkataraman G,
Paulson JC and Sasisekharan R: Glycomics: An integrated systems
approach to structure-function relationships of glycans. Nat
Methods. 2:817–824. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Freire-de-Lima L: Sweet and sour: The
impact of differential glycosylation in cancer cells undergoing
epithelial-mesenchymal transition. Front Oncol. 4:592014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H
and Jia L: Glycomic alterations are associated with multidrug
resistance in human leukemia. Int J Biochem Cell Biol.
44:1244–1253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma H, Miao X, Ma Q, Zheng W, Zhou H and
Jia L: Functional roles of glycogene and N-glycan in multidrug
resistance of human breast cancer cells. IUBMB Life. 65:409–422.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kudo T, Nakagawa H, Takahashi M, Hamaguchi
J, Kamiyama N, Yokoo H, Nakanishi K, Nakagawa T, Kamiyama T,
Deguchi K, et al: N-glycan alterations are associated with drug
resistance in human hepatocellular carcinoma. Mol Cancer. 6:322007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Qin H, Li T, Cheng K, Dong J, Tian
M, Chai N, Guo H, Li J, You X, et al: Characterization of
site-specific glycosylation of secreted proteins associated with
multi-drug resistance of gastric cancer. Oncotarget. 7:25315–25327.
2016.PubMed/NCBI
|
|
11
|
Zhou SM, Cheng L, Guo SJ, Wang Y,
Czajkowsky DM, Gao H, Hu XF and Tao SC: Lectin RCA-I specifically
binds to metastasis-associated cell surface glycans in
triple-negative breast cancer. Breast Cancer Res. 17:362015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fry SA, Afrough B, Lomax-Browne HJ, Timms
JF, Velentzis LS and Leathem AJ: Lectin microarray profiling of
metastatic breast cancers. Glycobiology. 21:1060–1070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao SC, Li Y, Zhou J, Qian J, Schnaar RL,
Zhang Y, Goldstein IJ, Zhu H and Schneck JP: Lectin microarrays
identify cell-specific and functionally significant cell surface
glycan markers. Glycobiology. 18:761–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Shen L, Xu L, Sun X, Zhou J and Wu
S: Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by
siRNA inhibits the growth of human gastric cancer. Mol Med Report.
4:497–503. 2011.
|
|
15
|
Shen L, Yu M, Xu X, Gao L, Ni J, Luo Z and
Wu S: Knockdown of β3GnT8 reverses 5-fluorouracil resistance in
human colorectal cancer cells via inhibition the biosynthesis of
polylactosamine-type N-glycans. Int J Oncol. 45:2560–2568. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
An HJ, Kronewitter SR, de Leoz ML and
Lebrilla CB: Glycomics and disease markers. Curr Opin Chem Biol.
13:601–607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Syed P, Gidwani K, Kekki H, Leivo J,
Pettersson K and Lamminmäki U: Role of lectin microarrays in cancer
diagnosis. Proteomics. 16:1257–1265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishida H, Togayachi A, Sakai T, Iwai T,
Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al: A novel
β1,3-N-acetylglucosaminyltransferase (β3Gn-T8), which synthesizes
poly-N-acetyllactosamine, is dramatically upregulated in colon
cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Janik ME, Litynska A and Vereecken P: Cell
migration-the role of integrin glycosylation. Biochim Biophys Acta.
1800:545–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Christie DR, Shaikh FM, Lucas JA IV, Lucas
JA III and Bellis SL: ST6Gal-I expression in ovarian cancer cells
promotes an invasive phenotype by altering integrin glycosylation
and function. J Ovarian Res. 1:32008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou S, Hang Q, Isaji T, Lu J, Fukuda T and
Gu J: Importance of membrane-proximal N-glycosylation on integrin
β1 in its activation and complex formation. FASEB J. 30:4120–4131.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seales EC, Jurado GA, Brunson BA,
Wakefield JK, Frost AR and Bellis SL: Hypersialylation of beta1
integrins, observed in colon adenocarcinoma, may contribute to
cancer progression by up-regulating cell motility. Cancer Res.
65:4645–4652. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CH, Wang SH, Liu CH, Wu YL, Wang WJ,
Huang J, Hung JS, Lai IR, Liang JT and Huang MC:
β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated
invasive phenotypes and negatively correlates with metastasis in
colorectal cancer. Carcinogenesis. 35:1258–1266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nalla AK, Asuthkar S, Bhoopathi P, Gujrati
M, Dinh DH and Rao JS: Suppression of uPAR retards
radiation-induced invasion and migration mediated by integrin
β1/FAK signaling in medulloblastoma. PLoS One. 5:e130062010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yun SP, Ryu JM and Han HJ: Involvement of
β1-integrin via PIP complex and FAK/paxillin in
dexamethasone-induced human mesenchymal stem cells migration. J
Cell Physiol. 226:683–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
